Your Source for Venture Capital and Private Equity Financings
Select An Article
Back to Archive
Gelesis Closes $22M Equity Financing
BOSTON, MA, Clinical stage biotechnology company focused on the development of first-in-class products to induce weight loss and improve glycemic control, has raised $22 million.
Subscribe to Daily VC Alerts